Lin Chen

Lin Chen is a seasoned clinical safety physician with extensive experience in oncology across multiple pharmaceutical companies. Currently serving as a Clinical Safety Physician at BioNTech SE since January 2023, Lin has previously held key roles including Global Drug Safety Physician at Innovent Biologics and Product Safety Leader at AbbVie, overseeing safety for numerous oncology assets in clinical development and post-marketing. Lin's background encompasses positions at Bayer Pharmaceuticals, Daiichi Sankyo, AstraZeneca, Novartis, Sanofi, and Bristol Myers Squibb, where responsibilities included leading global safety initiatives and pharmacovigilance for oncology and immuno-oncology products. Lin's educational credentials include an M.D. from The Second Military Medical University, an M.S. in Obesity/Metabolism, and a Ph.D. candidacy in Oncology and Pharmacology from Rutgers/UMDNJ.